Sofiva Genomics Co.,Ltd.

Sofiva Genomics Co.,Ltd.verified

6615.TWO

Price:

$29.85

Market Cap:

$644.56M

Sofiva Genomics Co.,Ltd. provides genetic testing services in Taiwan and internationally. The company offers prenatal services, including thalassemia carrier screening; tests for microdeletion syndromes and single-gene abnormalities; detection of common chromosome abnormalities, selected microdeletions syndromes, and selected skeletal dysplasia genetic mutations; multiple genetic diseases detection; folate metabolism genetic screening; spinal muscular atrophy carrier screening; fragile X syndrome carrier screening; congenital infection screening; risk assessment for early/late-onset preeclampsia; maternal serum screening for down syndrome; and karyotyping. It also provides cancer services, s...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

2017-01-06

Stock Exchange

TWO

Ticker

6615.TWO

The PE Ratio as of December 2025 (TTM) for Sofiva Genomics Co.,Ltd. (6615.TWO) is -63.51

According to Sofiva Genomics Co.,Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -63.51. This represents a change of -28.30% compared to the average of -88.58 of the last 4 quarters.

Sofiva Genomics Co.,Ltd. (6615.TWO) Historical PE Ratio (quarterly & annually)

How has 6615.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Sofiva Genomics Co.,Ltd. over the last ten years is 35.85. The current -63.51 PE Ratio has changed -17814.70% with respect to the historical average. Over the past ten years (40 quarters), 6615.TWO's PE Ratio was at its highest in in the September 2024 quarter at 161.88. The PE Ratio was at its lowest in in the June 2025 quarter at -412.50.

Quarterly (TTM)
Annual

Average

35.85

Median

27.76

Minimum

18.30

Maximum

76.39

Sofiva Genomics Co.,Ltd. (6615.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sofiva Genomics Co.,Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 316.79%

Maximum Annual PE Ratio = 76.39

Minimum Annual Increase = -42.04%

Minimum Annual PE Ratio = 18.30

Quarterly (TTM)
Annual
YearPE RatioChange
202446.56-39.04%
202376.39316.79%
202218.330.14%
202118.30-42.04%
202031.5831.85%

Sofiva Genomics Co.,Ltd. (6615.TWO) Average PE Ratio

How has 6615.TWO PE Ratio performed in the past?

The current PE Ratio of Sofiva Genomics Co.,Ltd. (6615.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

47.09

5-year avg

38.23

10-year avg

35.85

Sofiva Genomics Co.,Ltd. (6615.TWO) PE Ratio vs. Peers

How is 6615.TWO’s PE Ratio compared to its peers?

Sofiva Genomics Co.,Ltd.’s PE Ratio is less than Bioray Biotech Co., Ltd (20.56), less than TFBS Bioscience Inc. (-12.68), less than Original BioMedicals Co., Ltd. (-10.78), less than TaiwanJ Pharmaceuticals Co., Ltd. (-25.02), less than Health & Life Co., Ltd. (-37.83), less than Vectorite Biomedical Inc. (-27.18), less than EBM Technologies Incorporated (63.11), less than Welgene Biotech Co.,Ltd. (185.95), less than Sunder Biomedical Tech. Co., Ltd. (-50.25), less than AmCad BioMed Corporation (-17.54),

Build a custom stock screener for Sofiva Genomics Co.,Ltd. (6615.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sofiva Genomics Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sofiva Genomics Co.,Ltd. (6615.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sofiva Genomics Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Sofiva Genomics Co.,Ltd.'s PE Ratio?

How is the PE Ratio calculated for Sofiva Genomics Co.,Ltd. (6615.TWO)?

What is the highest PE Ratio for Sofiva Genomics Co.,Ltd. (6615.TWO)?

What is the 3-year average PE Ratio for Sofiva Genomics Co.,Ltd. (6615.TWO)?

What is the 5-year average PE Ratio for Sofiva Genomics Co.,Ltd. (6615.TWO)?

How does the current PE Ratio for Sofiva Genomics Co.,Ltd. (6615.TWO) compare to its historical average?